Connecticut General Statutes 20-617 – Prescriptions: Notation of drug quantity, expiration date, generic name and drug manufacturer and MedWatch program information. Label information for generic drug substitutions
(a) Each pharmacist shall include on the label of each prescription container: (1) The quantity of prescribed drug placed in such container, in addition to any other information required by law, and (2) a prominently printed expiration date based on the manufacturer’s recommended conditions of use and storage that can be read and understood by the ordinary individual. The expiration date required pursuant to subdivision (2) of this subsection shall be no later than the expiration date determined by the manufacturer.
Terms Used In Connecticut General Statutes 20-617
- Administration: means the direct application of a drug or device to the body of a patient or research subject by injection, inhalation, ingestion or any other means. See Connecticut General Statutes 20-571
- Drug: means (A) an article recognized in the official United States Pharmacopoeia, official Homeopathic Pharmacopoeia of the United States or official National Formulary, or any supplement to any of them, (B) an article intended for use in the diagnosis, cure, mitigation, treatment or prevention of disease in humans or other animals, (C) an article, other than food, intended to affect the structure or any function of the body of humans or any other animal, and (D) an article intended for use as a component of any article specified in this subdivision, but does not include a device. See Connecticut General Statutes 20-571
- Pharmacist: means an individual who is licensed to practice pharmacy under the provisions of §. See Connecticut General Statutes 20-571
- Prescription: means a lawful order of a prescribing practitioner transmitted either orally, in writing or by electronic means for a drug or device for a specific patient. See Connecticut General Statutes 20-571
(b) In addition to the information required to be included on the label of each prescription container pursuant to subsections (a) and (c) of this section, each pharmacist shall include on the label of each prescription container or on the receipt or other similar packaging in which the prescription is contained for a drug sold only by generic name, as defined in § 20-14a, and not by brand name, as defined in said section: (1) The name of the manufacturer of the generic drug placed in the container, and (2) the Internet web site address and toll-free telephone number for the United States Food and Drug Administration‘s safety information and adverse event reporting program (MedWatch).
(c) In addition to the information required to be included on the label of each prescription container pursuant to subsections (a) and (b) of this section, if a pharmacist substitutes a generic name drug for a brand name drug, such pharmacist shall include on the label of the prescription container: (1) The name of the generic drug placed in the container, and (2) the brand name of the drug that the generic drug was substituted for.